Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate telomerase reverse transcriptase (TERT) – an enzyme which plays a major role in aging-related diseases and in cellular senescence. Neuromagen's pipeline includes drugs for neurodegenerative diseases such as ALS and Alzheimer's, type 1 diabetes, fertility, and cardiovascular diseases.
Location: Israel, Southern, Beersheba
Member count: 1-10
Founded date: 2021
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 02.11.2021 | Israeli dr... | Israeli-designed molecules tha... | - | - | timesofisr... |